Passer aux informations produits
1 de 2

TIMELEAF

CONJURAN

CONJURAN

Prix habituel

Hello! To provide you with the pricing information, please register your account with all required information. We’ll verify your information and promptly send you a passcode.

 

Prix habituel

Hello! To provide you with the pricing information, please register your account with all required information. We’ll verify your information and promptly send you a passcode.

 

Prix promotionnel

Hello! To provide you with the pricing information, please register your account with all required information. We’ll verify your information and promptly send you a passcode.

 

En vente Épuisé

Conjuran is an innovative intraarticular injection designed to alleviate knee pain and improve joint function in patients suffering from osteoarthritis (OA). The active ingredient in Conjuran is sodium polynucleotide, with a concentration of 40mg/2ml per injection. This treatment has been clinically proven to be safe and effective for individuals with moderate or less severe osteoarthritis, providing substantial pain relief and promoting joint health.

2ml x 5syr

Mechanism of Action

The sodium polynucleotide in Conjuran has shown potential as both an anti-inflammatory and chondroprotective agent. This dual action is critical in managing osteoarthritis:

  • Anti-Inflammatory Properties: Sodium polynucleotide reduces inflammation in the knee joint, thereby alleviating pain and swelling.
  • Chondroprotective Properties: It helps in protecting and rejuvenating the cartilage, slowing down the degenerative process associated with osteoarthritis.

Benefits of Conjuran:

  • Pain Reduction: Clinical studies have demonstrated that Conjuran can reduce knee pain by nearly 60%, with effects lasting for up to six months post-administration.
  • Long-Lasting Relief: Patients typically experience significant pain relief maintained for six months following the injection course.
  • Minimal Adverse Reactions: Approximately 99.5% of patients report no adverse reactions, making Conjuran a safe option for knee OA management. Only a minor 0.5% of patients may experience mild adverse effects.
  • Improved Quality of Life
  • Reduced Intake of NSAIDs
  • Improved Trophism of the Cartilage

Afficher tous les détails